BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10087976)

  • 41. Osteoporosis pseudoglioma syndrome: treatment of spinal osteoporosis with intravenous bisphosphonates.
    Zacharin M; Cundy T
    J Pediatr; 2000 Sep; 137(3):410-5. PubMed ID: 10969269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study on the safety of rapid infusion and the efficacy of incadronate against bone metastasis of breast cancer].
    Oura S; Sakurai T; Yoshimura G; Tamaki T; Umemura T; Kokawa Y; Naito Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1623-8. PubMed ID: 10553421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain.
    Ernst DS; Tannock IF; Winquist EW; Venner PM; Reyno L; Moore MJ; Chi K; Ding K; Elliott C; Parulekar W
    J Clin Oncol; 2003 Sep; 21(17):3335-42. PubMed ID: 12947070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral clodronate in breast cancer patients with bone metastases: a randomized study.
    Kristensen B; Ejlertsen B; Groenvold M; Hein S; Loft H; Mouridsen HT
    J Intern Med; 1999 Jul; 246(1):67-74. PubMed ID: 10447227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of adjuvant clodronate therapy for prevention of bone metastasis in breast cancer].
    Horváth Z
    Magy Onkol; 2002; 46(4):361-4. PubMed ID: 12563361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid.
    Rossini M; Viapiana O; Ramonda R; Bianchi G; Olivieri I; Lapadula G; Adami S
    Rheumatology (Oxford); 2009 Jul; 48(7):773-8. PubMed ID: 19406908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new schedule for clodronate treatment in patients with breast cancer and bone metastases.
    Beghé F; Luzzani M
    Ann N Y Acad Sci; 1993 Nov; 698():367-71. PubMed ID: 8279777
    [No Abstract]   [Full Text] [Related]  

  • 48. Re: A randomized controlled trial of Intravenous clodronate.
    Crosby V; Wilcock A; Corcoran R
    J Pain Symptom Manage; 1998 May; 15(5):266-8. PubMed ID: 9654830
    [No Abstract]   [Full Text] [Related]  

  • 49. Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture.
    Rovetta G; Monteforte P; Balestra V
    Drugs Exp Clin Res; 2000; 26(1):25-30. PubMed ID: 10761534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.
    Machado M; Cruz LS; Tannus G; Fonseca M
    Clin Ther; 2009 May; 31(5):962-79. PubMed ID: 19539097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clodronate in the prevention and treatment of skeletal metastasis.
    Gulley J; Dahut WL
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A patient with gastric cancer complicated with severe DIC and multiple bone metastasis showing a high response to combination of TS-1 and CDDP].
    Yoshioka S; Tsujinaka T; Kida H; Hirao M; Fujitani K
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):403-6. PubMed ID: 12669401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Double-blind trial of oral clodronate in breast cancer patients with bone metastases].
    Paterson AH; Powles TJ; Kanis JA; McCloskey E; Hanson J; Ashley S
    Bull Cancer; 1993; 80(10 Suppl):50-6. PubMed ID: 8081032
    [No Abstract]   [Full Text] [Related]  

  • 54. Clodronate prevents prosthetic migration: a randomized radiostereometric study of 50 total knee patients.
    Hilding M; Ryd L; Toksvig-Larsen S; Aspenberg P
    Acta Orthop Scand; 2000 Dec; 71(6):553-7. PubMed ID: 11145380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [89SrCl2 in the treatment of cancer patients with bone metastasis and pain].
    Sun D; Chu Y; Lou C; Wang QJ; Zhan HW; He GQ
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):499-501. PubMed ID: 16188153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of intramuscular clodronate on bone mass and metabolism in osteoporotic women.
    Gnudi S; Lisi L; Fini M; Malavolta N
    Int J Tissue React; 2001; 23(1):33-7. PubMed ID: 11392061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clodronate in erosive osteoarthrosis of the hand: efficacy for pain and function recovery].
    Saviola G; Santoro L
    G Ital Med Lav Ergon; 2000; 22(4):328-31. PubMed ID: 11284157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Epidural calcitonin administration in the treatment of the pain caused by bone metastases].
    González Navarro A; González Hernández MJ; Molinero Aparicio T; Zimann Mansfeld H
    Rev Clin Esp; 1987 Jun; 181(1):26-8. PubMed ID: 3628882
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of concomitant administration of clodronate and estramustine phosphate on their bioavailability in patients with metastasized prostate cancer.
    Kylmälä T; Castrén-Kortekangas P; Seppänen J; Ylitalo P; Tammela TL
    Pharmacol Toxicol; 1996 Sep; 79(3):157-60. PubMed ID: 8884875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study.
    Robertson AG; Reed NS; Ralston SH
    J Clin Oncol; 1995 Sep; 13(9):2427-30. PubMed ID: 7666103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.